A 13-minute section on a latest episode of CBS’s 60 Minutes seemed to be a information story on Novo Nordisk’s weight-loss drug Wegovy, however was really a sponsored promotion violating federal rules, in response to the nonprofit public well being advocacy group Physicians Committee.
The group filed a grievance with the Meals and Drug Administration final week, arguing that the section, which aired on January 1, violates the FDA’s “truthful stability” requirement. This regulation requires that drug commercials give a good stability to a drug’s dangers and advantages.
The Physicians Committee claims that CBS’s 60 Minutes acquired promoting funds from Novo Nordisk previous to the protection, and that the aired section solely included specialists who had additionally been paid by Novo Nordisk. The section lauded the drug with phrases and phrases comparable to “extremely efficient,” “protected,” “spectacular,” “fabulous,” and “sturdy,” however did not delve into uncomfortable side effects or various remedies and techniques for weight reduction.
Learn three remaining paragraphs | Feedback